Factors influencing exacerbation and mortality in bronchiectasis patients in Hong Kong

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the factors related to exacerbation and mortality in adults with non-cystic fibrosis bronchiectasis in Hong Kong. It will assess the prevalence, clinical presentation, and outcomes of bronchiectasis, which is characterized by repeated exacerbations leading to increased hospital admissions and healthcare costs. The study will involve patients who are clinically stable and have a confirmed diagnosis of bronchiectasis through high-resolution computed tomography. The findings will help inform management plans for this condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients aged 18 years or older
2. Clinically stable for at least 4 weeks prior to enrollment (defined as no symptoms of exacerbation, no requirement for supplemental antibiotic therapy)
3. Diagnosis of bronchiectasis defined by high-resolution computed tomography scan

Exclusion Criteria:

1. History of cystic fibrosis; hypogammaglobulinemia; allergic bronchopulmonary aspergilosis
2. Those who are unable to give consent

Where it's running

• Chinese University of Hong
  Hong Kong, Please Select, Hong Kong Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CTX-187 first-in-human test in healthy people and people with chronic bronchiectasis and Pseudomonas infection

  This study tests CTX-187 to see if it is safe and tolerable when given as IV infusions to healthy adults and adults with chronic bronchiectasis and Pseudomonas aeruginosa infection.

  Recruiting Phase 1 Centauri Therapeutics Limited · Groningen · NCT07708116

• Tele-Pulmonary Rehabilitation for Chronic Lung Diseases

  This study tests whether a remote tele-rehabilitation program helps people with chronic lung diseases start and stick with pulmonary rehab better than usual center-based care.

  Recruiting at 2 sites Tel-Aviv Sourasky Medical Center · Ashkelon and 1 other locations · NCT07666841

• Azithromycin added to usual care to see if it lowers bronchiectasis flare-ups

  This trial tests whether taking azithromycin daily for a year reduces bronchiectasis-related flare-ups in adults with non-cystic fibrosis bronchiectasis.

  Recruiting Phase 4 Assiut University · Asyut · NCT07608328

• Wearable sensors and AI to detect chest infection flare-ups in adults with cystic fibrosis or bronchiectasis

  This study will try wearable sensors and AI to see if changes in breathing or heart rate can spot chest infection flare-ups early in adults with cystic fibrosis or bronchiectasis who are starting IV antibiotics.

  Recruiting Papworth Hospital NHS Foundation Trust · Cambridge, Cambridgeshire · NCT07289100

• Home use of the LibAirty airway clearance system for adults with bronchiectasis

  This project will see if using the LibAirty airway clearance system at home reduces pulmonary exacerbations and improves symptoms for adults with bronchiectasis.

  Recruiting at 3 sites Synchrony-Medical, Ltd · Birmingham, Alabama and 2 other locations · NCT07135284

• Autologous Basal Layer Stem Cells to Treat Bronchiectasis

  Researchers will test autologous basal layer stem cells delivered through the airways to see if they can safely improve lung tissue in adults with bronchiectasis.

  Recruiting at 2 sites Phase 1 Ruijin Hospital · Qionghai, Hainan and 1 other locations · NCT06987214

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.